These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab. Storey PP; Tauqeer Z; Yonekawa Y; Todorich B; Wolfe JD; Shah SP; Shah AR; Koto T; Abbey AM; Morizane Y; Sharma P; Wood EH; Morizane-Hosokawa M; Pendri P; Pancholy M; Harkey S; Jeng-Miller KW; Obeid A; Borkar DS; Chen E; Williams P; Okada AA; Inoue M; Shiraga F; Hirakata A; Shah CP; Prenner J; Garg S; Am J Ophthalmol; 2019 Mar; 199():200-208. PubMed ID: 30552891 [TBL] [Abstract][Full Text] [Related]
28. Infectious and noninfectious endophthalmitis after intravitreal bevacizumab. Jonas JB; Spandau UH; Rensch F; Von Baltz S; Schlichtenbrede F J Ocul Pharmacol Ther; 2007 Jun; 23(3):240-2. PubMed ID: 17593007 [TBL] [Abstract][Full Text] [Related]
29. Bacterial contamination of needles used for intravitreal injections: a prospective, multicenter study. Stewart JM; Srivastava SK; Fung AE; Mahmoud TH; Telander DG; Hariprasad SM; Ober MD; Mruthyunjaya P Ocul Immunol Inflamm; 2011 Feb; 19(1):32-8. PubMed ID: 21034310 [TBL] [Abstract][Full Text] [Related]
30. Incidence of acute endophthalmitis after triamcinolone-assisted pars plana vitrectomy. Sakamoto T; Enaida H; Kubota T; Nakahara M; Yamakiri K; Yamashita T; Yokoyama M; Hata Y; Murata T; Miyata K; Uemura A; Kimura W; Ishibashi T Am J Ophthalmol; 2004 Jul; 138(1):137-8. PubMed ID: 15234294 [TBL] [Abstract][Full Text] [Related]
31. Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment. Gregori NZ; Flynn HW; Schwartz SG; Rosenfeld PJ; Vaziri K; Moshfeghi AA; Fortun JA; Kovach JL; Dubovy SR; Albini TA; Davis JL; Berrocal AM; Smiddy WE Ophthalmic Surg Lasers Imaging Retina; 2015 Jun; 46(6):643-8. PubMed ID: 26114845 [TBL] [Abstract][Full Text] [Related]
32. Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics. Bhavsar AR; Stockdale CR; Ferris FL; Brucker AJ; Bressler NM; Glassman AR; Arch Ophthalmol; 2012 Jun; 130(6):809-10. PubMed ID: 22801859 [No Abstract] [Full Text] [Related]
33. Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab. Damasceno NP; Horowitz SA; Damasceno EF Ocul Immunol Inflamm; 2016; 24(1):118-9. PubMed ID: 24749654 [TBL] [Abstract][Full Text] [Related]
34. Acute endophthalmitis after intravitreal injection and preventive effect of preoperative topical antibiotics. Park Y; Kim KS; Park YH J Ocul Pharmacol Ther; 2013 Dec; 29(10):900-5. PubMed ID: 24067061 [TBL] [Abstract][Full Text] [Related]
35. Intravitreal bevacizumab: safety of multiple doses from a single vial for consecutive patients. Ng DS; Kwok AK; Chan CW; Li WW Hong Kong Med J; 2012 Dec; 18(6):488-95. PubMed ID: 23223649 [TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Fileta JB; Scott IU; Flynn HW Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):143-9. PubMed ID: 24635156 [TBL] [Abstract][Full Text] [Related]
37. Endophthalmitis after intravitreal injection: decreasing incidence and clinical outcome-8-year results from a tertiary ophthalmic referral center. Nentwich MM; Yactayo-Miranda Y; Schwarzbach F; Wolf A; Kampik A; Mino de Kaspar H Retina; 2014 May; 34(5):943-50. PubMed ID: 24136408 [TBL] [Abstract][Full Text] [Related]
38. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Bhatt SS; Stepien KE; Joshi K Retina; 2011 Nov; 31(10):2032-6. PubMed ID: 21659941 [TBL] [Abstract][Full Text] [Related]